Insider Selling: Intuitive Surgical (NASDAQ:ISRG) SVP Sells $254,499.36 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 464 shares of Intuitive Surgical stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $548.49, for a total transaction of $254,499.36. Following the transaction, the senior vice president owned 131 shares of the company’s stock, valued at $71,852.19. This represents a 77.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Friday, December 12th, Mark Brosius sold 4,500 shares of Intuitive Surgical stock. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00.

Intuitive Surgical Trading Up 0.4%

Shares of NASDAQ:ISRG opened at $556.86 on Thursday. The stock has a market cap of $199.62 billion, a PE ratio of 73.66, a price-to-earnings-growth ratio of 5.10 and a beta of 1.68. The stock’s fifty day simple moving average is $536.26 and its two-hundred day simple moving average is $505.77. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.84 EPS. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Intuitive Surgical

Large investors have recently modified their holdings of the company. Tobam raised its stake in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC purchased a new stake in shares of Intuitive Surgical in the 2nd quarter valued at $27,000. Greykasell Wealth Strategies Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at $27,000. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the period. Finally, 1248 Management LLC bought a new stake in Intuitive Surgical in the first quarter worth $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on ISRG shares. HSBC raised their price target on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Wells Fargo & Company upped their price target on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research report on Friday, December 12th. Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Finally, BTIG Research raised their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $609.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.